Narra J
Vol. 6 No. 3 (2026): December 2026 (In Press)

Enhancing immunogenicity: Evaluating the polio antigen immune response in hexavalent vaccine formulations

Tiza Wuri Mawaddah (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia
Professor Nidom Foundation, Surabaya, Indonesia)

Elisa D. Pratiwi (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia
Professor Nidom Foundation, Surabaya, Indonesia
Global Biosains Teknologi, Malang, Indonesia)

Arif Rahman Sadjuri (PT. Bio Farma, Bandung, Indonesia)
Dimas Tri Nugroho (PT. Bio Farma, Bandung, Indonesia)
Arip Hidayat (PT. Bio Farma, Bandung, Indonesia)
Acep R. Wijayadikusumah (PT. Bio Farma, Bandung, Indonesia)
Astria N. Nidom (Professor Nidom Foundation, Surabaya, Indonesia
Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia)

Zakiyyan I. Ayyuba (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia
Professor Nidom Foundation, Surabaya, Indonesia)

Kadek Rachmawati (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia)
Suwarno Suwarno (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia)
Jola Rahmahani (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia)
Setyarina Indrasari (Professor Nidom Foundation, Surabaya, Indonesia
Global Biosains Teknologi, Malang, Indonesia)

Reviany V. Nidom (Professor Nidom Foundation, Surabaya, Indonesia
Global Biosains Teknologi, Malang, Indonesia
Riset AIRC Indonesia, Surabaya, Indonesia)

Chairul A. Nidom (Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia
Professor Nidom Foundation, Surabaya, Indonesia
Global Biosains Teknologi, Malang, Indonesia
Riset AIRC Indonesia, Surabaya, Indonesia)



Article Info

Publish Date
15 Oct 2026

Abstract

Hexavalent vaccines simplify childhood immunization by combining antigens against six diseases in a single formulation; however, the immunogenicity of each component must be evaluated. This study assessed poliovirus-specific immunoglobulin G (IgG) responses elicited by candidate hexavalent vaccines containing different doses of Sabin strain-derived inactivated poliovirus vaccine (sIPV). A preclinical study was conducted using 40 Wistar rats allocated to five groups: hexavalent vaccine containing low-, medium-, or high-dose sIPV; pentavalent vaccine combined with sIPV; or adjuvant control. Each group comprised four male and four female rats. The animals received primary immunization at week 0 and booster doses at weeks 4 and 8. Serotype-specific IgG titers were measured at weeks 0, 4, 8, and 12 using indirect enzyme-linked immunosorbent assay. Antibody responses were analyzed using repeated-measures analysis of variance. Titers against poliovirus serotypes 1, 2, and 3 were negligible at baseline and remained low at week 4. Marked responses were observed in all vaccinated groups at week 8, followed by lower titers at week 12. Significant between-group differences were detected at weeks 8 and 12 for serotype 1 (p<0.001 and p=0.010), serotype 2 (both p<0.001), and serotype 3 (both p=0.010). However, no consistent dose–response pattern was observed across serotypes, time points, or sexes. All animals survived and gained body weight during follow-up. The candidate hexavalent formulations elicited marked poliovirus-specific binding-IgG responses, supporting further preclinical evaluation using validated serological and serotype-specific neutralization assays.

Copyrights © 2026






Journal Info

Abbrev

main

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Description

Narra J is a multidisciplinary journal and it is published three times (April, August, December) a year. The objective is to promote articles on infection, public health, global health, tropical infection, one health and diseases in tropics. Narra J publishes original research work across all ...